Stockreport

Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand

Femasys Inc.  (FEMY) 
PDF ATLANTA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more [Read more]